In this study, we have observed that the somatic mutations on known HCC-related driver genes, such as as TERT, TP53 and CTNNB1 in cfDNA, were consistently and dynamically correlated with tumor burden during patient follow-up. The gene discussed is TP53; the disease is hepatocellular carcinoma.